Advertisement

The Role of Tumour Necrosis Factor in Lymphoid Tissue Formation and Function

  • Manolis Pasparakis
  • Eleni Douni
  • Lena Alexopoulou
  • George Kollias
Chapter
Part of the NATO ASI Series book series (NSSA, volume 293)

Abstract

Tumour necrosis factor and lymphotoxin-α (TNF and LTα) are multipotent cytokines showing a wide range of activities that extend beyond their well characterised pleiotropic proinflammatory properties to include diverse signals for cellular differentiation, proliferation and death. TNF is produced in response to various stimuli mainly by macrophages and T cells and is shown to be bioactive both as a transmembrane protein and as a homotrimeric secreted molecule (Vasali, 1992; Kriegler et al, 1988). LTα, originally identified as a major product of lymphocytes, exists as a secreted molecule only in a homotrimeric form (Paul and Ruddle, 1988), but it may also accumulate on the cellular membrane of lymphocytes when complexed with LTβ, a type II transmembrane protein that is another member of the TNF ligand family (Browning et al, 1993). LTα1β2 trimers signal exclusively through the LTα receptor(s) (Crowe et al, 1994), while TNFα and LTα share the same cell surface receptors, designated p55 and p75 TNF-R, which show common but also differential activities depending on the cell type in which they operate (Vandenabeele et al, 1995). p75 TNF-R signalling has been mainly implicated in lymphocyte proliferation (Espevik et al, 1990; Tartaglia et al, 1991) while the p55 TNF-R is generally known to mediate apoptosis (Tartaglia et al, 1993), a process in which the p75 TNF-R mav also be involved (Grell et al. 1995: Zheng et al, 1995).

Keywords

Tumor Necrosis Factor Receptor Contact Hypersensitivity Lymphoid Structure Tertiary Lymphoid Structure Tumor Necrosis Factor Signalling 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Akassoglou, K., Probert, L., Kontogeorgos, G. and Kollias, G., 1997, Astrocyte-specific but not neuron-specific transmembrane TNF triggers inflammation and degeneration in the central nervous system of transgenic mice. J.Immunol., 158: 438.PubMedGoogle Scholar
  2. Bromberg, J.S., Chavin, K.D. and Kunkel, S.L., 1992, Anti-tumour necrosis factor antibodies suppress cell-mediated immunity in vivo. J.Immunol., 148: 3412.PubMedGoogle Scholar
  3. Browning, J.L., Ngamek, A., Lawton, P., DeMarinis, J., Tizard, R., Chow, E.P., Hession, C., O’Brine Greco, B., Foley, S.F. and Ware, C.F., 1993, Lymphotoxin beta, a novel member of the TNF family that forms a heteromeric complex with lymphotoxin on the cell surface. Cell. 72: 847.PubMedCrossRefGoogle Scholar
  4. Crowe, P.D., VanArsdale, T.L., Walter, B.N., Ware, C.F., Hession, C., Ehrenfels, B., Browning, J.L., Din, W.S., Goodwin, R.G. and Smith, C.A., 1994, A lymphotoxin-beta-specific receptor. Science. 264: 707.PubMedCrossRefGoogle Scholar
  5. Cumberbatch, M., and Kimber, I., 1992. Dermal tumour necrosis factor-alpha induces dendritic cell migration to draining lymph nodes, and possibly provides one stimulus for Langerhan’s cell migration. Immunology. 75: 257.PubMedGoogle Scholar
  6. Dalton, D.K., Pitts-Meek, S., Keshav, S., Figari, I.S., Bradley, A. and Stewart, T.A., 1993 Multiple defects of immune cell function in mice with disrupted interferon-gamma genes. Science. 259: 1739.PubMedCrossRefGoogle Scholar
  7. Douni, E., Akassoglou, K., Alexopoulou, L., Georgopoulos, S., Haralambous, S., Hill, S., Kassiotis, G., Kontoyiannis, D., Pasparakis, M., Plows, D., Probert, L. and Kollias, G. 1996, Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis. J. Inflamm., 47: 27.Google Scholar
  8. Erickson, S.L., de Sauvage, F.J., Kikly, K., Carver-Moore, K., Pitts-Meek, S., Gillett, N., Sheehan, K.C., Schreiber, R.D., Goeddel, D.V. and Moore, M.W., 1994, Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptors-deficient mice. Nature. 372: 560.PubMedCrossRefGoogle Scholar
  9. Espevik, T., Brockhaus, M., Loetscher, H., Nonstad, U. and Shalaby, R., 1990, Characterization of binding and biological effects of monoclonal antibodies against a human tumour necrosis factor receptor. J.Exp.Med., 171: 415.PubMedCrossRefGoogle Scholar
  10. Georgopoulos, S., Plows, D. and Kollias, G., 1996, Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J. Inflamm. 46: 86.PubMedGoogle Scholar
  11. Grell, M., Douni, E., Wajant, H., Lohden, M., Clauss, M., Maxeiner, B., Georgopoulos, S., Lesslauer, W., Kollias, G., Pfizenmaier, K. and Scheurich, P., 1995, The trans-membrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell. 83: 793.PubMedCrossRefGoogle Scholar
  12. Harty, J.T. and Bevan, M.J., 1995, Specific immunity to Listeria monocytogenes in the absence of IFN amma. Immunity. 3: 109.PubMedCrossRefGoogle Scholar
  13. Le Hir, M., Bluethmann, H., Kosco Vilbois, M.H., Müller, M., di Padova, F., Moore, M., Ryffel, B. and Eugster, H.P., 1996, Differentiation of follicular dendritic cells and full antibody responses require tumor necrosis factor receptor-1 signaling. J.Exp.Med., 183: 2367.PubMedCrossRefGoogle Scholar
  14. Keffer, J., Probert, L., Cazlaris, H., Georgopoulos, S., Kaslaris, E., Kioussis, D. and Kollias, G., 1991, Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J., 10: 4025.PubMedGoogle Scholar
  15. Kondo, S., Wang, B., Fujisawa, H., Shivji, G.M., Echtenacher, B., Mak, T.W., and Sauder, D.N., 1995, Effect of gene-targeted mutation in TNF receptor (p55) on contact hypersensitivity and ultraviolet B-induced immunosuppression. J.Immunol., 155: 3801.PubMedGoogle Scholar
  16. Kratz, A., Campos-Neto, A., Hanson, M.S. and Ruddle, N.H., 1996, Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J.Exp.Med., 183: 1461.PubMedCrossRefGoogle Scholar
  17. Kriegler, M., Perez, C., DeFay, K., Albert, I. and Lu, S.D., 1988, A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell. 53: 45.PubMedCrossRefGoogle Scholar
  18. Kurimoto, I. and Streilein, J.W., 1992, cis-urocanic supression of contact hypersensitivity induction is mediated via tumour necrosis factor-á. J.Immunol. 148: 3072.PubMedGoogle Scholar
  19. Leprince, C., Cohen-Kaminsky, S., Berrih-Aknin, S., Vernet-Der Garabedian, B., Treton, D., Galanaud, P., and Richard, Y., 1990, Thymic B cells from myasthenia gravis patients are activated B cells. Phenotypic and functional analysis. J.Immunol., 145: 2115.PubMedGoogle Scholar
  20. Matsumoto, M., Mariathasan, S., Nahm, M.H., Baranyay, F., Peschon, J.J. and Chaplin, D.D., 1996a, Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers. Science. 271: 1289.PubMedCrossRefGoogle Scholar
  21. Matsumoto, M., Lo, S.F., Carruthers, C.J., Min, J., Mariathasan, S., Huang, G., Plas, D.R., Martin, S.M., Geha, R.S., Nahm, M.H. and Chaplin, D.D. (1996b). Affinity maturation without germinal centres in lymphotoxin-alpha-deficient mice. Nature. 382: 462.PubMedCrossRefGoogle Scholar
  22. Neumann, B., Machleidt, T., Lifka, A., Pfeffer, K., Vestweber, D., Mak, T.W., Holzmann, B. and Kronke, M., 1996, Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J.Immunol., 156: 1587.PubMedGoogle Scholar
  23. Pasparakis, M., Alexopoulou, L., Episkopou, V. and Kollias, G., 1996, Immune and inflammatory responses in TNF alpha-deficient mice: a critical requirement for TNF alpha in the formation of primary B cell follicles, follicular dendritic cell networks and germinal centers, and in the maturation of the humoral immune response. J.Exp.Med., 184: 1397.PubMedCrossRefGoogle Scholar
  24. Pasparakis, M., Alexopoulou, L., Douni, E. and Kollias, G., 1996b, Tumour necrosis factors in immune regulation: everything that’s interesting is new! Cytokine and Growth Factor Review, 7: 223.CrossRefGoogle Scholar
  25. Pasparakis, M., Alexopoulou, L., Grell, M., Pfizenmaier, K., Bluethmann, H. and Kollias, G., 1997, Intact Peyer’s patch organogenesis yet defective formation of B lymphocyte follicles in peripheral lymphoid organs of mice deficient for tumour necrosis factor and its 55 kDa receptor. (Submitted for publication).Google Scholar
  26. Paul, N.L., and Ruddle, N.H., 1988, Lymphotoxin. Annu.Rev.ImmunoL 6: 407.PubMedCrossRefGoogle Scholar
  27. Pfeffer, K., Matsuyama, T., Kundig, T.M., Wakeham, A., Kishihara, K., Shahinian, A., Wiegmann, K., Ohashi, P.S., Kronke, M. and Mak, T.W., 1993, Mice deficient for the 55 kd tumor necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell. 73: 457.PubMedCrossRefGoogle Scholar
  28. Piguet, P.F., Grau, G.E., Hauser, C. and Vassalli, P., 1991, Tumour necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J.Exp.Med., 173: 673.PubMedCrossRefGoogle Scholar
  29. Probert, L., Plows, D., Kontogeorgos, G. and Kollias, G., 1995b, The type I interleukin-1 receptor acts inseries with tumor necrosis factor (TNF) to induce arthritis in TNF-transgenic mice. Eur.J.Immunol., 25: 1794.PubMedCrossRefGoogle Scholar
  30. Probert, L., Keffer, J., Corbella, P., Cazlaris, H., Patsavoudi, E., Stephens, S., Kaslaris, E., Kioussis, D. and Kollias, G., 1993, Wasting, ischemia, and lymphoid abnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. J.Immunol., 151: 1894.PubMedGoogle Scholar
  31. Probert, L., Akassoglou, K., Pasparakis, M., Kontogeorgos, G. and Kollias, G., 1995a, Spontaneous inflammatory demyelinating disease in transgenic mice showing central nervous system-specific expression of tumor necrosis factor alpha. Proc.Natl.Acad. Sci. USA. 92: 11294.PubMedCrossRefGoogle Scholar
  32. Rothe, J., Lesslauer, W., Lotscher, H., Lang, Y., Koebel, P., Kontgen, F., Althage, A., Zinkernagel, R., Steinmetz, M. and Bluethmann, H., 1993, Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature. 364: 798.PubMedCrossRefGoogle Scholar
  33. Tartaglia, L.A., Weber, R.F., Figari, I.S., Reynolds, C., Palladino, M.A. and Goeddel D.V., 1991, The two different receptors for tumour necrosis factor mediate distinct cellular responses. Proc.Natl.Acad.Sci. USA. 88: 9292.PubMedCrossRefGoogle Scholar
  34. Tartaglia, L.A., Ayres, T.M., Wong, G.H. and Goeddel, D.V., 1993, A novel domain within the 55 kd TNF receptor signals cell death. Cell. 74: 845.PubMedCrossRefGoogle Scholar
  35. De Togni, P., Goellner, J., Ruddle, N.H., Streeter, P.R., Fick, A., Mariathasan, S., Smith, S.C., Carlson, R., Shornick, L.P., Strauss Schoenberger, J. and Chaplin, D., 1994, Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science. 264: 703.PubMedCrossRefGoogle Scholar
  36. Vandenabeele, P. Declercq, W., Beyaert, R. and Fiers, W., 1995, Two tumour necrosis factor receptors: structure and function. Trends Cell Biol. 5: 392.PubMedCrossRefGoogle Scholar
  37. Vassali, P., 1992, The pathophysiology of tumour necrosis factor. Annu.Rev.Immunol. 10: 411.CrossRefGoogle Scholar
  38. Wang, B., Kondo, S., Shivji, G.M., Fujisawa, H., Mak, T.W. and Sauder, D.N., 1996, Tumour necrosis factor receptor II (p75) signalling is required for the migration of Langerhans’ cells. Immunology. 88: 284.PubMedCrossRefGoogle Scholar
  39. Zheng, L., Fisher, G., Miller, R.E., Peschon, J., Lynch, D.H. and Lenardo, M.J., 1995, Induction of apoptosis in mature T cells by tumour necrosis factor. Nature. 377: 348.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 1997

Authors and Affiliations

  • Manolis Pasparakis
    • 1
  • Eleni Douni
    • 1
  • Lena Alexopoulou
    • 1
  • George Kollias
    • 1
  1. 1.Department of Molecular GeneticsHellenic Pasteur InstituteAthens, HellasGreece

Personalised recommendations